Urinary proteomic profiles of prostate cancer with different risk of progression and correlation with histopathological features-Reference-Cited by-同舟云学术

Urinary proteomic profiles of prostate cancer with different risk of progression and correlation with histopathological features

Published:2021-04 Issue: Volume:51 Page:151704
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Bergamini Stefania,Caramaschi Stefania,Monari Emanuela,Martorana Eugenio,Salviato Tiziana,Mangogna Alessandro,Balduit Andrea,Tomasi Aldo,Canu Pina,Bellei Elisa

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference42 articles.

1. Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide;Hassanipour-Azgomi;Prostate Int,2016

2. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology;Mohler;J Natl Compr Canc Netw,2019

3. Prostate cancer, version 2.2014;Mohler;J Natl Compr Canc Netw,2014

4. Unit BPO. Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy;Beasley;Radiat Oncol,2008

5. An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk;Williams;Int J Radiat Oncol Biol Phys,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of machine learning models for diagnosis and prognosis of cancer by urinary proteomics, based on the FLEMENGHO cohort;American Journal of Cancer Research;2024

2. Research of Prostate Cancer Urinary Diagnostic Biomarkers by Proteomics: The Noteworthy Influence of Inflammation;Diagnostics;2023-04-01